Clinical Trial Detail

Clinical Trials

Clinical Trial Detail

Assessing Compliance With Mercaptopurine Treatment in Younger Patients With Acute Lymphoblastic Leukemia in First Remission

Complete title: ACCL1033, A Comprehensive Approach to Improve Medication Adherence in Pediatric ALL

Research Study Number ACCL1033
 
Principal Investigator Eric Chow, MD
 
Phase NA

Research Study Description

This randomized phase III trial studies compliance to a mercaptopurine treatment intervention compared to standard of care in younger patients with acute lymphoblastic leukemia in remission. Assessing ways to help patients who have acute lymphoblastic leukemia to take their medications as prescribed may help them in taking their medications more consistently and may improve treatment outcomes.

Eligibility Criteria (must meet the following to participate in this study)

** For Eligibility information, please click on the "Look up trial at NIH" link above. **

Other eligibility criteria may apply.

Research Study Number ACCL1033
 
Contact Claire Wharton
 
Telephone 206/884-4494
 
E-mail
 

Keywords: Hematologic Malignancies; Leukemia; Lymphoproliferative Disorders; Pediatric Cancers, Miscellaneous; Leukemia, Lymphoid; Immunoproliferative Disorders

Disclaimer: We update this information regularly. However, what you read today may not be completely up to date.

Please remember:

  • Talk to your health care providers first before making decisions about your health care.
  • Whether you are eligible for a research study depends on many things. There are specific requirements to be in research studies. These requirements are different for each study.

Subscribe to an RSS feed of all trials